热门资讯> 正文

BRIEF-Windtree Advances Lower Cost Manufacturing Of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel

2025-06-27 05:15

June 26 (Reuters) - Windtree Therapeutics Inc WINT.O:

WINDTREE ADVANCES LOWER COST MANUFACTURING OF PHEXXI, EVOFEM’S HORMONE-FREE, ON-DEMAND PRESCRIPTION CONTRACEPTIVE GEL
WINDTREE THERAPEUTICS: CONTRACT INKED WITH OUTSIDE U.S MANUFACTURER TO CUT PHEXXI MANUFACTURING COSTS BY OVER 50% BY END OF 2026
WINDTREE THERAPEUTICS INC: TECH TRANSFER UNDERWAY WITH VALIDATION BATCH MANUFACTURING EXPECTED TO BEGIN IN 2026

Source text: ID:nGNX21CYlX

Further company coverage: WINT.O

((Reuters.Briefs@thomsonreuters.com;))

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。